BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38760795)

  • 1. A newborn Screening Programme for Inborn errors of metabolism in Galicia: 22 years of evaluation and follow-up.
    Couce ML; Bóveda MD; Castiñeiras DE; Vázquez-Mosquera ME; Barbosa-Gouveia S; De Castro MJ; Iglesias-Rodríguez AJ; Colón C; Cocho JA; Sánchez P
    Orphanet J Rare Dis; 2024 May; 19(1):202. PubMed ID: 38760795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency.
    McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L
    Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism.
    Wang W; Yang J; Xue J; Mu W; Zhang X; Wu W; Xu M; Gong Y; Liu Y; Zhang Y; Xie X; Gu W; Bai J; Cram DS
    BMC Med Genet; 2019 Jan; 20(1):3. PubMed ID: 30612563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Newborn Screening Program in the Community of Madrid: evaluation of positive cases.].
    Cambra Conejero A; Martínez Figueras L; Ortiz Temprado A; Blanco Soto P; Martín Rivada Á; Palomino Pérez L; Cañedo Villarroya E; Pedrón Giner C; Quijada Fraile P; Martín-Hernández E; García Silva MT; Chumillas Calzada S; Bellusci M; Belanger-Quintana A; Stanescu S; Martínez-Pardo Casanova M; Moráis López A; Bergua Martínez A; Ruiz-Salas P; Pérez González B; Ugarte M; Ruano MLF
    Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33372917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: regional experience and high incidence of carnitine deficiency.
    Couce ML; Sánchez-Pintos P; Diogo L; Leão-Teles E; Martins E; Santos H; Bueno MA; Delgado-Pecellín C; Castiñeiras DE; Cocho JA; García-Villoria J; Ribes A; Fraga JM; Rocha H
    Orphanet J Rare Dis; 2013 Jul; 8():102. PubMed ID: 23842438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective screening for inborn errors of metabolism by tandem mass spectrometry at Sohag University Hospital, Egypt.
    Magdy RM; Abd-Elkhalek HS; Bakheet MA; Mohamed MM
    Arch Pediatr; 2022 Jan; 29(1):36-43. PubMed ID: 34848132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.
    Bentler K; Zhai S; Elsbecker SA; Arnold GL; Burton BK; Vockley J; Cameron CA; Hiner SJ; Edick MJ; Berry SA;
    Mol Genet Metab; 2016 Sep; 119(1-2):75-82. PubMed ID: 27477829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New Inborn Errors of Metabolism added in the French program of neonatal screening].
    Touati G; Gorce M; Oliver-Petit I; Broué P; Ausseil J
    Med Sci (Paris); 2021 May; 37(5):507-518. PubMed ID: 34003097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and long-term follow-up of infants with inborn errors of metabolism identified in an expanded screening programme.
    Couce ML; Castiñeiras DE; Bóveda MD; Baña A; Cocho JA; Iglesias AJ; Colón C; Alonso-Fernández JR; Fraga JM
    Mol Genet Metab; 2011 Dec; 104(4):470-5. PubMed ID: 22000754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
    Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
    Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7-year study in eastern coastal areas of China.
    Men S; Liu S; Zheng Q; Yang S; Mao H; Wang Z; Gu Y; Tang X; Wang L
    Mol Genet Genomic Med; 2023 Jun; 11(6):e2152. PubMed ID: 36787440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
    Goddard P
    J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.
    Janeiro P; Jotta R; Ramos R; Florindo C; Ventura FV; Vilarinho L; Tavares de Almeida I; Gaspar A
    Eur J Pediatr; 2019 Mar; 178(3):387-394. PubMed ID: 30617651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
    Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.